US Stock MarketDetailed Quotes

CRGX CARGO Therapeutics

Watchlist
  • 4.180
  • +0.010+0.24%
Close Mar 28 16:00 ET
  • 4.180
  • 0.0000.00%
Post 19:49 ET
192.50MMarket Cap-1.12P/E (TTM)

CARGO Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
93.74%187.37M
43.42%50.13M
64.09%47.11M
177.13%49.32M
167.63%40.81M
178.13%96.71M
217.64%34.96M
185.71%28.71M
17.8M
15.25M
Selling and administrative expenses
110.21%43.97M
34.74%10.63M
72.58%11.18M
206.70%11.86M
283.72%10.3M
287.53%20.92M
344.70%7.89M
310.00%6.48M
--3.87M
--2.69M
-General and administrative expense
110.21%43.97M
34.74%10.63M
72.58%11.18M
206.70%11.86M
283.72%10.3M
287.53%20.92M
344.70%7.89M
310.00%6.48M
--3.87M
--2.69M
Research and development costs
89.20%143.4M
45.95%39.5M
61.62%35.93M
168.92%37.46M
142.82%30.5M
158.03%75.79M
193.22%27.07M
162.52%22.23M
--13.93M
--12.56M
Operating profit
-93.74%-187.37M
-43.42%-50.13M
-64.09%-47.11M
-177.13%-49.32M
-167.63%-40.81M
-178.13%-96.71M
-217.64%-34.96M
-185.71%-28.71M
-17.8M
-15.25M
Net non-operating interest income expense
514.11%20.06M
41.71%4.67M
504.36%5.4M
762.80%4.99M
433.89%5.01M
166.11%3.27M
221.64%3.29M
161.32%894K
578K
-1.5M
Non-operating interest income
311.89%20.06M
41.71%4.67M
504.36%5.4M
762.80%4.99M
4,666.67%5.01M
--4.87M
--3.29M
--894K
--578K
--105K
Non-operating interest expense
--0
--0
--0
--0
--0
-67.54%1.6M
--0
--0
--0
--1.6M
Other net income (expense)
95.85%-195K
107.47%31K
97.40%-199K
97.32%-17K
-100.25%-10K
-279.97%-4.7M
-1,052.78%-415K
-883.80%-7.65M
-634K
4M
Gain on sale of security
----
----
----
----
----
630.67%6.45M
--0
----
----
--6.45M
Special income (charges)
--0
--0
--0
--0
--0
---2.32M
--0
--0
--0
---2.32M
-Less:Other special charges
----
----
----
----
----
--2.32M
--0
----
----
--2.32M
Other non- operating income (expenses)
97.79%-195K
107.47%31K
97.40%-199K
97.32%-17K
92.75%-10K
-40,086.36%-8.84M
-6,816.67%-415K
-765,500.00%-7.65M
---634K
---138K
Income before tax
-70.66%-167.5M
-41.64%-45.44M
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
Income tax
Net income
-70.66%-167.5M
-41.64%-45.44M
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
Net income continuous Operations
-70.66%-167.5M
-41.64%-45.44M
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
---17.85M
---12.75M
Minority interest income
Net income attributable to the parent company
-70.66%-167.5M
-41.64%-45.44M
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-70.66%-167.5M
-41.64%-45.44M
-18.15%-41.91M
-148.42%-44.35M
-180.94%-35.81M
-139.67%-98.15M
-133.30%-32.08M
-188.73%-35.47M
-17.85M
-12.75M
Basic earnings per share
77.50%-3.72
-22.04%-0.95
4.06%-0.88
-120.96%-1.02
-163.95%-0.87
-685.96%-16.53
-10.25%-0.7785
-45.37%-0.9172
-0.4616
-0.3296
Diluted earnings per share
77.50%-3.72
-22.04%-0.95
4.06%-0.88
-120.96%-1.02
-163.95%-0.87
-685.96%-16.53
-10.25%-0.7785
-45.37%-0.9172
-0.4616
-0.3296
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 93.74%187.37M43.42%50.13M64.09%47.11M177.13%49.32M167.63%40.81M178.13%96.71M217.64%34.96M185.71%28.71M17.8M15.25M
Selling and administrative expenses 110.21%43.97M34.74%10.63M72.58%11.18M206.70%11.86M283.72%10.3M287.53%20.92M344.70%7.89M310.00%6.48M--3.87M--2.69M
-General and administrative expense 110.21%43.97M34.74%10.63M72.58%11.18M206.70%11.86M283.72%10.3M287.53%20.92M344.70%7.89M310.00%6.48M--3.87M--2.69M
Research and development costs 89.20%143.4M45.95%39.5M61.62%35.93M168.92%37.46M142.82%30.5M158.03%75.79M193.22%27.07M162.52%22.23M--13.93M--12.56M
Operating profit -93.74%-187.37M-43.42%-50.13M-64.09%-47.11M-177.13%-49.32M-167.63%-40.81M-178.13%-96.71M-217.64%-34.96M-185.71%-28.71M-17.8M-15.25M
Net non-operating interest income expense 514.11%20.06M41.71%4.67M504.36%5.4M762.80%4.99M433.89%5.01M166.11%3.27M221.64%3.29M161.32%894K578K-1.5M
Non-operating interest income 311.89%20.06M41.71%4.67M504.36%5.4M762.80%4.99M4,666.67%5.01M--4.87M--3.29M--894K--578K--105K
Non-operating interest expense --0--0--0--0--0-67.54%1.6M--0--0--0--1.6M
Other net income (expense) 95.85%-195K107.47%31K97.40%-199K97.32%-17K-100.25%-10K-279.97%-4.7M-1,052.78%-415K-883.80%-7.65M-634K4M
Gain on sale of security --------------------630.67%6.45M--0----------6.45M
Special income (charges) --0--0--0--0--0---2.32M--0--0--0---2.32M
-Less:Other special charges ----------------------2.32M--0----------2.32M
Other non- operating income (expenses) 97.79%-195K107.47%31K97.40%-199K97.32%-17K92.75%-10K-40,086.36%-8.84M-6,816.67%-415K-765,500.00%-7.65M---634K---138K
Income before tax -70.66%-167.5M-41.64%-45.44M-18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M
Income tax
Net income -70.66%-167.5M-41.64%-45.44M-18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M
Net income continuous Operations -70.66%-167.5M-41.64%-45.44M-18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M---17.85M---12.75M
Minority interest income
Net income attributable to the parent company -70.66%-167.5M-41.64%-45.44M-18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -70.66%-167.5M-41.64%-45.44M-18.15%-41.91M-148.42%-44.35M-180.94%-35.81M-139.67%-98.15M-133.30%-32.08M-188.73%-35.47M-17.85M-12.75M
Basic earnings per share 77.50%-3.72-22.04%-0.954.06%-0.88-120.96%-1.02-163.95%-0.87-685.96%-16.53-10.25%-0.7785-45.37%-0.9172-0.4616-0.3296
Diluted earnings per share 77.50%-3.72-22.04%-0.954.06%-0.88-120.96%-1.02-163.95%-0.87-685.96%-16.53-10.25%-0.7785-45.37%-0.9172-0.4616-0.3296
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More